Skip to main content


Fig. 2 | Journal of Foot and Ankle Research

Fig. 2

From: IL-17 cytokines in bone healing of diabetic Charcot arthropathy patients: a prospective 2 year follow-up study

Fig. 2

Plasma levels of IL-IL-17E (pg/ml) in Charcot patients (n = 26), diabetes control patients (n = 20) and healthy donors (n = 20). IL-17E was not significantly different between Charcot patients, diabetic control patients and healthy subjects at inclusion into the study (p = 0.73) (2a). At 2 years, IL-17E was significantly higher for Charcot patients relative diabetic controls (p = 0.021) and relative healthy (p = 0.002) but not between diabetic controls and healthy (p = 0.32). Plasma IL-17E in Charcot patients had not changed significantly at 2 years relative value at inclusion (p = 0.23) (2a). IL-17E in Charcot patients had increased significantly at 4 months relative value at inclusion (p < 0.001) (2b). Mean ± SEM

Back to article page